John Stansel
Stock Analyst at JP Morgan
(2.23)
# 3,697
Out of 5,182 analysts
14
Total ratings
71.43%
Success rate
4.48%
Average return
Main Sectors:
Stocks Rated by John Stansel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Neutral | $45 → $41 | $43.50 | -5.75% | 5 | Mar 19, 2026 | |
| HSIC Henry Schein | Maintains: Overweight | $78 → $92 | $77.20 | +19.17% | 2 | Feb 25, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $23 → $26 | $20.95 | +24.11% | 2 | Feb 5, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $272 → $184 | $179.22 | +2.67% | 2 | Jul 29, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $148 → $149 | $196.63 | -24.22% | 1 | Nov 17, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $259 → $261 | $263.43 | -0.92% | 1 | Nov 17, 2023 | |
| ONON On Holding AG | Initiates: Buy | $31 | $35.93 | -13.72% | 1 | Apr 19, 2022 |
Centene
Mar 19, 2026
Maintains: Neutral
Price Target: $45 → $41
Current: $43.50
Upside: -5.75%
Henry Schein
Feb 25, 2026
Maintains: Overweight
Price Target: $78 → $92
Current: $77.20
Upside: +19.17%
Alignment Healthcare
Feb 5, 2026
Maintains: Overweight
Price Target: $23 → $26
Current: $20.95
Upside: +24.11%
Molina Healthcare
Jul 29, 2025
Maintains: Neutral
Price Target: $272 → $184
Current: $179.22
Upside: +2.67%
Quest Diagnostics
Nov 17, 2023
Maintains: Neutral
Price Target: $148 → $149
Current: $196.63
Upside: -24.22%
Labcorp Holdings
Nov 17, 2023
Maintains: Overweight
Price Target: $259 → $261
Current: $263.43
Upside: -0.92%
On Holding AG
Apr 19, 2022
Initiates: Buy
Price Target: $31
Current: $35.93
Upside: -13.72%